Evidence map›Paper›PMID 31253187›Full record

ArticleJournal of cardiothoracic surgery2019

Long-term outcome after mitral valve replacement using biological versus mechanical valves.

Ayse Cetinkaya, Julia Poggenpohl, Karin Bramlage, Stefan Hein, Mirko Doss, Peter Bramlage, Markus Schönburg, Manfred Richter

Abstract read
In one paragraph

Article in Journal of cardiothoracic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2024
    Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Endomyocardial fibrosis.Cardiovascular diagnosis and therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayse CetinkayaDepartment of Cardiac Surgery, Kerckhoff-Heart Center Bad Nauheim, 61231, Bad Nauheim, Germany.
Julia PoggenpohlDepartment of Cardiac Surgery, Kerckhoff-Heart Center Bad Nauheim, 61231, Bad Nauheim, Germany.
Karin BramlageInstitute for Pharmacology and Preventive Medicine, Bahnhofstraße 20, 49661, Cloppenburg, Germany.
Stefan HeinDepartment of Cardiac Surgery, Kerckhoff-Heart Center Bad Nauheim, 61231, Bad Nauheim, Germany.
Mirko DossDepartment of Cardiac Surgery, Kerckhoff-Heart Center Bad Nauheim, 61231, Bad Nauheim, Germany.
Peter BramlageInstitute for Pharmacology and Preventive Medicine, Bahnhofstraße 20, 49661, Cloppenburg, Germany. peter.bramlage@ippmed.de.ORCID http://orcid.org/0000-0003-4970-2110
Markus SchönburgDepartment of Cardiac Surgery, Kerckhoff-Heart Center Bad Nauheim, 61231, Bad Nauheim, Germany.
Manfred RichterDepartment of Cardiac Surgery, Kerckhoff-Heart Center Bad Nauheim, 61231, Bad Nauheim, Germany.

Funding

Edwards Lifesciences not applicable
6 · The paper itself

Abstract

backgroundThis study compared long-term outcomes of biological and mechanical mitral valve replacement (MVR) in patients requiring replacement of the mitral valve where repair was not feasible.

methodsA single-centre registry of patients receiving MVR between 2005 and 2015 was established. Thirty-day mortality and long-term outcomes were analysed and compared.

resultsThree hundred twenty four patients underwent MVR (265 biological; 59 mechanical valves). Patients receiving biological valves were older (p < 0.001), had a higher log EuroSCORE (p < 0.001) and received less minimally invasive surgery (p < 0.001). Immediate procedural mortality was 1.9%, which only occurred in the biological valve group. At 30 days, 9.0% of patients had died, 4.0% experienced stroke, 8.0% received a pacemaker and 10.5% suffered an acute renal failure. The rate of re-thoracotomy (14.2%) was lower in the biological (12.5%) than in the mechanical valve group (22.0%; adjOR 0.45 [0.20-1.00]; p = 0.050). Frequent long-term complications were stroke (9.2%) and bleeding (4.8%), with bleeding complications being higher in the mechanical valve group (p = 0.009). During the follow-up period biological valves showed a numerically higher survival rate during the first years, which shifted after 3 years in favour of mechanical valves. At 10 years, survival rates were 62.4% vs. 77.1% in the biological and mechanical valve groups (p = 0.769). Hazard ratio after adjustment was 0.833 (95% CI 0.430-1.615).

conclusionThese data confirm that mechanical valve implantation is associated with an increased risk of bleeding. While there was a potential survival benefit during the first years after surgery for patients receiving a biological valves the difference became insignificant after a follow-up of 10 years.

Indexed as

BioprosthesisHeart Valve ProsthesisFemaleFollow-Up StudiesGermanyHeart Valve Prosthesis ImplantationHumansIncidenceMaleMiddle AgedMitral ValveMitral Valve InsufficiencyPostoperative ComplicationsReoperationSurvival RateTime FactorsBiological valveMechanical valveMitral valve replacement

Identifiers

PMID31253187
PMCPMC6599286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.